Polymorphisms in transporter genes and chemotherapy response in acute myeloid leukemia (AML) patients from Israel

被引:0
|
作者
Risch, A
Müller, P
Asher, N
Bar-Cohen, S
Bartsch, H
Rund, D
机构
[1] Deutsch Krebsforschungszentrum, D-6900 Heidelberg, Germany
[2] Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91010 Jerusalem, Israel
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
561
引用
收藏
页码:144 / 144
页数:1
相关论文
共 50 条
  • [1] Impact of Transporter Genes Polymorphisms in Standard Induction of Acute Myeloid Leukemia
    Eduardo Megias, Juan
    Montesinos, Pau
    Jose Herrero, Maria
    Moscardo, Federico
    Boso, Virginia
    Martinez-Cuadron, David
    Rojas, Luis
    Rodriguez-Veiga, Rebeca
    Boluda, Blanca
    Martinez, Jesus
    Sanz, Jaime
    Lopez, Francisca
    Cano, Isabel
    Lancharro, Aima
    Cervera, Jose
    Hervas, David
    Luis Poveda, Jose
    Alino, Salvador F.
    Angel Sanz, Miguel
    BLOOD, 2015, 126 (23)
  • [3] POLYMORPHISMS IN ABC TRANSPORTER GENES ARE ASSOCIATED WITH COMPLETE MOLECULAR RESPONSE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA PATIENTS
    Vivona, D.
    Lima, L.
    Bueno, C.
    Hirata, R.
    Hirata, M.
    Luchessi, A.
    Zanichelli, M.
    Chiattone, C.
    Guerra-Shinohara, E.
    HAEMATOLOGICA, 2012, 97 : 211 - 211
  • [4] SINGLE NUCLEOTIDE POLYMORPHISMS OF TRANSPORTER GENES CAN PREDICT THE OUTCOME OF PEDIATRIC PATIENTS WITH ACUTE MYELOID LEUKEMIA IN JAPAN
    Aoki, Takahiro
    Shiba, Norio
    Tsujimoto, Shinichi
    Hayashi, Yasuhide
    Tawa, Akio
    Taga, Takashi
    Adachi, Souichi
    Tomizawa, Daisuke
    PEDIATRIC BLOOD & CANCER, 2024, 71 : S11 - S11
  • [5] Cost impact of Filgrastim as an adjunct to chemotherapy for patients with acute myeloid leukemia (AML).
    Lu, ZJ
    Luo, R
    Erder, H
    Heil, G
    Ganser, A
    Lechner, K
    Yin, JL
    Szer, J
    Barge, A
    BLOOD, 1996, 88 (10) : 826 - 826
  • [6] Cost impact of filgrastim as an adjunct to chemotherapy for patients with acute myeloid leukemia (AML).
    Lu, ZJ
    Shi, J
    Erder, MH
    Heil, G
    Ganser, A
    Lechner, K
    Yin, JL
    Szer, J
    Barge, A
    BLOOD, 1997, 90 (10) : 314 - 314
  • [7] Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia
    Eduardo Megias-Vericat, Juan
    Martinez-Cuadron, David
    Jose Herrero, Maria
    Rodriguez-Veiga, Rebeca
    Solana-Altabella, Antonio
    Boluda, Blanca
    Ballesta-Lopez, Octavio
    Cano, Isabel
    Acuna-Cruz, Evelyn
    Cervera, Jose
    Poveda, Jose Luis
    Sanz, Miguel Angel
    Alino, Salvador F.
    Montesinos, Pau
    PHARMACOGENETICS AND GENOMICS, 2021, 31 (06): : 133 - 139
  • [8] Role of Wnt/β-Catenin Signalling in Acute Myeloid Leukemia (AML) Cell Response to Chemotherapy
    Kamga, Paul Takam
    Cassaro, Adriana
    Dal Collo, Giada
    Adamo, Annalisa
    Gatti, Alessandro
    Carusone, Roberta
    Midolo, Martina
    Di Trapani, Mariano
    Resci, Federica
    Bonifacio, Massimiliano
    Krampera, Mauro
    BLOOD, 2016, 128 (22)
  • [9] Is It Time to Redefine Response in Elderly Patients with WHO-Acute Myeloid Leukemia (AML) Unfit for Intensive Chemotherapy?
    Pleyer, Lisa
    Burgstaller, Sonja
    Stauder, Reinhard
    Girschikofsky, Michael
    Sill, Heinz
    Schlick, Konstantin
    Thaler, Josef
    Halter, Britta
    Machherndl-Spandl, Sigrid
    Zebisch, Armin
    Pichler, Angelika
    Pfeilstoecker, Michael
    Autzinger, Eva-Maria
    Lang, Alois
    Geissler, Klaus
    Voskova, Daniela
    Geissler, Diermar
    Sperr, Wolfgang R.
    Hojas, Sabine
    Rogulj, Inga Mandac
    Andel, Johannes
    Greil, Richard
    BLOOD, 2015, 126 (23)
  • [10] Microarray analyses of oral punch biopsies from acute myeloid leukemia (AML) patients treated with chemotherapy
    Mougeot, Jean-Luc C.
    Bahrani-Mougeot, Farah K.
    Lockhart, Peter B.
    Brennan, Michael T.
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2011, 112 (04): : 446 - 452